The abstract is read at the publisher; the summary is JClub's.
A global multisociety harmonisation initiative has produced a unified, evidence-based framework for defining, diagnosing, grading, and managing acute-on-chronic liver failure (ACLF) worldwide.
- Why it matters: Different regional ACLF definitions limit patient stratification, organ dysfunction assessment, and comparability across studies, slowing progress in therapy development.
- What they did: The initiative integrates strengths of existing regional definitions and international perspectives to create a pragmatic, globally applicable consensus covering diagnosis, grading, management, and trial design.
- The result: Standardised, regulatory-aligned endpoints are expected to improve cross-study comparability, strengthen collaboration, and accelerate development of effective ACLF therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.